IDEAL Electrical™, a leading manufacturer of tools and supplies for electricians, proudly unveils the SureTrace™ Circuit Tracer Pro – a flagship addition to its trusted SureTrace line that offers ...

From "Project Mando" to a partnership with Hyosung HICO, here's a look at how the Memphis xAI project has played out since ...

The Supreme Court on Wednesday allowed President Trump to terminate for now, without cause, President Biden's appointees to the Consumer Product Safety Commission. The decision further limits a ...

Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis ...

BMRCL plans Phase-3 of Namma Metro, possibly affecting over 11,000 trees. Public consultations start to discuss tree cutting, shifting, and route alignment.

The Andhra Pradesh government has proposed the names of three senior officials from the water resources department to be included in the high-level panel being formed by the Centre to address ...

A new smart panel, developed by Vancouver-based Evectrix with public funding, transforms a conventional breaker panel into a “smart hub” that manages real-time energy usage and efficiently ...

Complete test of the Anker Solix Solarbank 3 Pro: discover this intelligent solar battery, easy to install, efficient, and optimized for residential self-consumption. Power, AI, compatibility, price, ...

A recent panel discussion on the many challenges journalism faces at the moment demonstrated the value of a good question. We five journalists on the panel weren’t able to answer all the questions ...

Phase 3 OASISplus data demonstrating benefit of donidalorsen for HAE patients who switched from other prophylactics published in JACI In Practice Provided by Business Wire Jul 21, 2025, 4:00:00 AM ...

Methods BOREAS, a phase 3, multicentre, double-blind, randomised trial was conducted at 275 sites in 24 countries and included patients with COPD and type 2 inflammation (screening blood eosinophils ...

Investing.com -- Viatris Inc. (NASDAQ: VTRS) stock fell 3.6% after the company announced that its Phase 3 study of MR-139 for blepharitis did not meet its primary endpoint. The randomized, double ...